Re: Bear
|
2
|
Resverlogix Corp.
|
Jun 06, 2020 05:50PM
|
Re: How & who comes up with valuations?
|
2
|
Zenith Epigenetics
|
Apr 17, 2024 01:27PM
|
Re: AGM & PP
|
2
|
Resverlogix Corp.
|
Nov 23, 2020 09:32AM
|
Re: RVX Status
|
2
|
Resverlogix Corp.
|
Nov 28, 2020 10:15AM
|
Re: Will we see 5 point MACE reduction results in BETONMACE
|
2
|
Resverlogix Corp.
|
Jun 18, 2019 11:14AM
|
Re: I think one major reason that,
|
2
|
Resverlogix Corp.
|
Nov 01, 2019 04:37PM
|
Re: MP's and MLA's
|
2
|
Resverlogix Corp.
|
May 15, 2021 09:50AM
|
Re: Two more clinical study sites added to the ZEN-3694/enzalutamid... mCRPC trial
|
2
|
Zenith Epigenetics
|
Sep 02, 2018 01:11PM
|
Re: AGM & PP
|
2
|
Resverlogix Corp.
|
Nov 24, 2020 04:32PM
|
Re: RRR %
|
2
|
Resverlogix Corp.
|
Jul 01, 2019 12:21PM
|
Re: I know US markets are closed...but geesh
|
2
|
Resverlogix Corp.
|
Nov 28, 2019 12:37PM
|
Re: Is anyone else seeing 0 lots available on the ask at $1.07?
|
2
|
Resverlogix Corp.
|
Mar 27, 2020 12:17PM
|
Re: Nasdaq listing requirements - Another reason for this raise?
|
2
|
Resverlogix Corp.
|
May 30, 2019 09:30AM
|
Re: Is a NASDAQ listing.....
|
2
|
Resverlogix Corp.
|
Jun 01, 2019 12:11PM
|
Re: Biotech’s – Full Disclosure can take weeks if not months
|
2
|
Resverlogix Corp.
|
Nov 13, 2019 09:38AM
|
Re: So what's our ceo's next move/plan? one thought ...
|
2
|
Resverlogix Corp.
|
Apr 25, 2023 04:38PM
|
Re: Zenith Epigenetics Announces Clinical Trial Collaboration with Pfizer
|
2
|
Zenith Epigenetics
|
Nov 21, 2018 06:52AM
|
Re: BETonMACE Placebo Estimate
|
2
|
Resverlogix Corp.
|
Feb 23, 2019 11:06AM
|
Re: USA ZHCLF investors
|
2
|
Zenith Epigenetics
|
Nov 01, 2022 05:57PM
|
Re: RVX AGM Q&A, post AGM-huddle, impressions
|
2
|
Resverlogix Corp.
|
Sep 20, 2018 08:17AM
|